Dernière mise à jour: Août 17, 2026
amazon
For eighteen months Tablet with Android abundantly available to quickly disappear from the counter and do not justify the hopes of users and manufacturers. Was released only a decent sample – Galaxy Tab 10.1, which reached the top on-iPad’om. But it is doubtful whether even he intended to compete with iPad 2. Low operating system functionality, low iron – it seems that Amazon will sell knowingly “weak” appareil.
It became known that foreign Internet giant Amazon sent out an invitation to media conference to be held on the 28th of this month. The letter did not contain any targets for future meetings, but despite this, the experts unanimously believe: the meeting will be presented to the tablet, which is expected from Amazon for a year. This is not the first device, which is unbranded and submitted to Amazon, and a proprietary reader Kindle has already purchased thousands of fans.
But the expected new product will be quite different. Tablet will have a color touch screen 7 inch screen, OS, Android Honeycomb interface with Amazon, and the approximate price – just $ 250. That price, according to some experts, will contribute to its popularity.
We look forward to the conference from which we learn about the performance and technical characteristics of the tablet.
Examen de cas scientifiques
Souhaitez-vous savoir si les programmes cliniques actuels, développements récents en recherche, ou des approches émergentes peuvent être adapté à votre situation individuelle?
Envoyez votre question à notre équipe scientifique. Le siège social de NBScience au Royaume-Uni coordonne les demandes de renseignements à travers le réseau international de centres médicaux, scientifiques, et consultants spécialisés.
- Examen des informations que vous fournissez
- Informations pertinentes sur la recherche et les programmes cliniques
- Une réponse claire et adaptée à votre situation
Aucune obligation. Votre question sera examinée de manière confidentielle.
Informations pédagogiques et de recherche uniquement. Ce service ne constituer un avis médical, diagnostic, ordonnance, ou un personnalisé recommandation de traitement.